Retrobulbar Methylprednisolone as Adjunctive Treatment in Optic Neuritis Trial

NCT04942002 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Optic Neuritis
Treatment
Methylprednisolone

Interventions

DRUG: Methylprednisolone Acetate 40 MG/ML [Depo-Medrol]
DRUG: Placebo Comparator: Standard treatment + placebo

Sponsor

Asociación para Evitar la Ceguera en México